Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

about

Adverse Drug Events Associated with sitagliptin Versus canagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Comparison Through a Meta-Analysis

P2860

Q58791926-D9F5BCE6-2507-46DE-A0AE-A3A1A3D6380F

P2860

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

Item

http://www.wikidata.org/entity/Q48286589

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@en

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@nl

type

Item

label

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@en

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@nl

prefLabel

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@en

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@nl

P1476

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

@en

P2093

Atsuko Chihara

http://www.w3.org/2001/XMLSchema#string

Aya Shiraki

http://www.w3.org/2001/XMLSchema#string

Fumi Uchida

http://www.w3.org/2001/XMLSchema#string

Hideo Ikeda

http://www.w3.org/2001/XMLSchema#string

Koichi Node

http://www.w3.org/2001/XMLSchema#string

Motoko Tago

http://www.w3.org/2001/XMLSchema#string

Shigeki Gondo

http://www.w3.org/2001/XMLSchema#string

Shigetaka Kuroki

http://www.w3.org/2001/XMLSchema#string

Taketo Iwamoto

http://www.w3.org/2001/XMLSchema#string

Yasufumi Uchida

http://www.w3.org/2001/XMLSchema#string

P2860

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

Obesity may attenuate the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patients.

Hypoglycemia, diabetes, and cardiovascular events.

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32).

Diabetes in older adults: a consensus report

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.

The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.

Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis

Effects of sitagliptin beyond glycemic control: focus on quality of life.

P304

631-639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/GGI.13235

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jun-Ichi Oyama

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29314506

http://www.w3.org/2001/XMLSchema#string

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

about

P2860

P2860

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698